Events

For event #2, AstraZeneca has another exciting line-up of speakers and start-ups as we discuss what the future of healthcare will look like, touching on the sustainability of scientific innovation and how science must take a more holistic approach to drive better patient outcomes. There will be a live panel discussion on mentoring and another showcase of innovative start-ups.
 

AstraZeneca: Healthcare of the Future: A Roadmap Towards Collaborative Value Creation Event #2 (Nov. 17, 2020)

The Original Forum for Life Sciences Providing Exclusive Access to FDA/CMS Regulators to Examine Shifting Regulatory and Reimbursement Policy.

FDA/CMS Summit 2020 (Dec. 7-9, 2020)

Year after year, the life sciences industry marks Informa Connect-CBI’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals. Join hundreds of your industry counterparts this December to unravel the complexities of the channel, navigate high-impact topics transforming trade and benchmark winning pharmacy and distribution frameworks.

Trade and Channel Strategies 2020 (Dec. 1-3, 2020)

Consistently highly acclaimed for top quality learning and networking. Led by the industry’s most authoritative government pricing experts, a must-attend meeting with timely analyses on evolving regulatory issues, industry benchmarking by hundreds of companies on prevailing MDRP trends and strategies for government reporting.

22nd Annual Medicaid and Government Pricing Congress (Dec. 14-17, 2020)

Pharma, biotech, and medical device professionals will convene to stay up to date on complex state & local transparency regulations, global compliance requirements and effective HCP engagements. From the changing regulatory landscape to the latest enforcement trends, this must-attend event provides your very best opportunity to benchmark with industry peers.

14th Annual Forum on Transparency, Aggregate Spend & HCP Engagement (Dec 7-10, 2020)

CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.

Rare Disease Innovation and Partnering Summit 2020 (Dec. 1-4, 2020)

A 360 degree view of the medical affairs landscape that brings together Investigator Initiated Sponsored Research (IISR), Expanded Access Programs (EAP) and Medical Publications & Communications.

Medical Affairs Congress (Dec. 1-3, 2020)

This gold standard event arms the industry with strategic approaches to improve contract operations, navigate class of trade complexities, streamline membership management and reduce revenue leakage to improve chargeback efficiency and the bottom line.

16th Annual Commercial Contracts & Chargebacks (Dec. 17-18, 2020)

Convening top Canadian compliance practitioners and leading experts to exchange ideas and discuss the impact of the latest laws, regulations and best practices for advancing compliance programs.

PCC Canada – 4th Annual Pharmaceutical Compliance Congress (Dec. 9-11, 2020)

Pharma & Patient USA (December 1-4, 2020, Virtual – formerly eyeforpharma Patient Summit) is where industry experts, patient leaders and key stakeholders unite to devise an advanced roadmap for patient centricity that goes above and beyond, prioritizing patient needs in the post-pandemic age.